These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21270668)

  • 81. Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
    Tsao AS; Miao J; Wistuba II; Vogelzang NJ; Heymach JV; Fossella FV; Lu C; Velasco MR; Box-Noriega B; Hueftle JG; Gadgeel S; Redman MW; Gandara DR; Kelly K
    J Clin Oncol; 2019 Oct; 37(28):2537-2547. PubMed ID: 31386610
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Malignant pleural mesothelioma.
    Chen SE; Pace MB
    Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
    van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
    Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Case of the season. Rapidly fatal bilateral malignant mesothelioma.
    Golla B; Singh SP; Pinkard NB; Klemm KM; Nath H
    Semin Roentgenol; 1998 Oct; 33(4):306-8. PubMed ID: 9800241
    [No Abstract]   [Full Text] [Related]  

  • 85. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients.
    Senyiğit A; Bayram H; Babayiğit C; Topçu F; Nazaroğlu H; Bilici A; Leblebici IH
    Respiration; 2000; 67(6):615-22. PubMed ID: 11124643
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma.
    Krüger S; Pauls S; Mottaghy FM; Buck AK; Schelzig H; Hombach V; Reske SN
    Nuklearmedizin; 2007; 46(6):239-43. PubMed ID: 18084678
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metastases in malignant pleural mesothelioma: a new radiological appearance.
    Fares M; Abbas O; Jamaleddine G; Bou-Khalil P
    Respirology; 2008 Sep; 13(5):746-7. PubMed ID: 18513248
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Malignant pleural mesothelioma: the standard of care and challenges for future management.
    van Meerbeeck JP; Scherpereel A; Surmont VF; Baas P
    Crit Rev Oncol Hematol; 2011 May; 78(2):92-111. PubMed ID: 20466560
    [TBL] [Abstract][Full Text] [Related]  

  • 91. European guidelines for the management of malignant pleural mesothelioma.
    van Thiel E; van Meerbeeck JP
    Pol Arch Med Wewn; 2010 Dec; 120(12):503-10. PubMed ID: 21178907
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.
    Keshava S; Rao LV; Pendurthi UR
    Sci Rep; 2016 Nov; 6():36829. PubMed ID: 27833109
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Images in cardiothoracic surgery. Localized fibrous mesothelioma: an extremely rare benign pleural tumor.
    Kotoulas C; Fotinou M; Tsaroucha E; Konstantinou M; Lioulias A
    Ann Thorac Surg; 2006 Jun; 81(6):2316. PubMed ID: 16731187
    [No Abstract]   [Full Text] [Related]  

  • 94. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma.
    Metintaş M; Ozdemir N; Işiksoy S; Kaya T; Ekici M; Erginel S; Harmanci E; Erdinç P; Ulgey N; Alataş F
    J Comput Assist Tomogr; 1995; 19(3):370-4. PubMed ID: 7790544
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of malignant pleural mesothelioma: current status and future directions.
    Dhalluin X; Scherpereel A
    Monaldi Arch Chest Dis; 2010 Jun; 73(2):79-85. PubMed ID: 20949774
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria.
    Kidd AC; Anderson O; Cowell GW; Weir AJ; Voisey JP; Evison M; Tsim S; Goatman KA; Blyth KG
    Thorax; 2022 Dec; 77(12):1251-1259. PubMed ID: 35110367
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Response evaluation in mesothelioma: Beyond RECIST.
    Cheng L; Tunariu N; Collins DJ; Blackledge MD; Riddell AM; Leach MO; Popat S; Koh DM
    Lung Cancer; 2015 Dec; 90(3):433-41. PubMed ID: 26443279
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Variability of tumor area measurements for response assessment in malignant pleural mesothelioma.
    Labby ZE; Straus C; Caligiuri P; MacMahon H; Li P; Funaki A; Kindler HL; Armato SG
    Med Phys; 2013 Aug; 40(8):081916. PubMed ID: 23927330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.